16 Mar 2017
QT Vascular Ltd. - Share Issuance in Settlement of Bond Repayment
Danny Lim and Caitlin have advised QT Vascular Ltd., which is listed on the SGX-ST Catalist, in the settlement of its second tranche due amount of US$2.3 million in respect of its 8% convertible bonds via the issuance of new shares in the company amounting to approximately 6.65% of its existing share capital.
QT Vascular is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. It collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.